In today’s Vivien T. Thomas Symposium at STS 2023, attendees will hear how they can help to mitigate disparities in care for patients undergoing congenital surgery—and how these steps can make a difference in care throughout patients’ lifetimes. “Clearly, health equity is one of the most important drivers of outcomes across a lifetime,” said Tara Karamlou, MD, MSc, who will present during today’s Vivien Thomas Symposium. “If you’re 80 and part of an underserved population, living below the poverty line, you’ve lived your life to that point. For a child in that situation, we as healthcare providers have a responsibility to address inequities in care, and to understand that some populations are uniquely at risk.” An important step in addressing patient care disparities lies in tackling provider disparities, Dr. Karamlou points out. “We know from extensive literature that if women take care of women, if African Americans take care of African Americans, the outcomes are better. If a provider is culturally competent, they can relate to those patients such that they come back for their visits, they stay in touch with their health care team.” Dr. Karamlou noted the importance of recognizing social determinants of health as new tools—such as the new STS adult congenital surgery risk model, which will be unveiled this morning at STS 2023—are implemented in the clinical setting. “Going forward, in addition to capturing mortality, factors such as quality of life and other patient-reported outcomes will need to be folded into the risk model,” she said. Whether attendees are adult cardiac surgeons, congenital cardiac surgeons, or thoracic surgeons, it’s critical to understand that adult congenital surgery is one of the most rapidly growing fields in the specialty, and that patients who have congenital conditions have unique risk factors. “Those patients circumscribe the entire cardiothoracic care spectrum,” Dr. Karamlou said. “An adult congenital patient is still an adult congenital patient, whether they’re undergoing CABG, a pulmonary valve repair, a diaphragm plication, or a lung transplant, you need to adequately capture and adjust for the risk of your patients.” “Whatever specialty you’re in, more accurately doing that among this growing population is going to pay dividends not just for you as a surgeon, but also for your program,” Dr. Karamlou added, “so that you can adequately get credit for the complexity of your operation.” “Social Determinants of Health: Mitigating health disparities across a patient’s lifespan in congenital cardiac surgery” will be presented today as part of the Vivien Thomas Symposium, beginning at 2:45 p.m. PT.  
Jan 20, 2023
3 min read
STS 2023 DAY 1 — Watch surgeons and intensivists square off about who’s in charge in the ICU as STS hosts a friendly debate bringing two top specialists together to help attendees develop the best care models for their institutions.  On Saturday, January 21 at 9:45 a.m. PT, a multidisciplinary panel will present the CT Ethics Forum, “For the Post-operative Patient in the ICU, Who Is in Charge and Who Is the Consultant? Surgeon or Intensivist?” As reimbursement changed for surgeons outside the OR, and as surgeons’ time for ICU care became unpredictable, intensivists began to enter the post-operative ICU arena. Andrea J. Carpenter MD, PhD, a cardiothoracic surgeon and Assistant Dean for Health System Science at University of Texas Health Science Center in San Antonio, will advocate for surgeon-directed management. Martin Zammert, MD, a surgical critical care physician who heads the cardiothoracic unit at Lahey Hospital & Medical Center in Burlington, Massachusetts, will make the case for intensivist-directed management. Both physicians will seize their best chance to persuade attendees about the merits of their specialty informing decision-making in a critical care setting. From their perspectives, a spectrum of opportunities will emerge for attendees to create the best care model at their institutions within available resources. “The bottom line is that the best model is a well-managed, protocol-driven team with clear lines of communication and shared responsibility. The caveats are challenging and involve deep respect and trust among the caregivers,” says debate moderator Joseph Zwischenberger, MD, a cardiothoracic surgeon at University of Kentucky HealthCare in Lexington. “Titles, egos, zealous trainees, and nursing bias can foil the best laid plans.” Dr. Zwischenberger adds that this ideal state is a delicate balance, reached by well-trained intensivists, surgeons and nurses, robust protocols, and buy-in from all concerned.
Jan 20, 2023
2 min read

Authors discuss two groundbreaking presentations that will happen at the 59th Annual Meeting of The Society of Thoracic Surgeons, which will reveal:

Jan 18, 2023
Tomorrow at STS 2023: A study of more than 100,000 patients reveals that, for patients with blockages in multiple arteries, those who opt for coronary artery bypass grafting (CABG) are less likely to die from their condition, less likely to need additional surgery, and less likely to have a heart attack than patients who choose to undergo a stent procedure. “The findings of our study were very convincing,” said J. Hunter Mehaffey MD, MSc, from the Department of Cardiovascular and Thoracic Surgery at West Virginia University. “The singular message to the public is that the optimal treatment for multivessel coronary artery disease—to improve not only long-term survival but also lower your risk of complications—is coronary artery bypass surgery.” The results from the study, “Contemporary Artery Bypass Grafting versus Multivessel Percutaneous Coronary Intervention in 100,000 Matched Medicare Beneficiaries,” will be presented at 9:05 a.m. PT on Sunday, January 22, during STS 2023. The background and rationale for this research project started with the publication of the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization, Dr. Mehaffey explained. “The cardiac surgery world was really shocked, because the guidelines downgraded the indications for CABG from a class 1 recommendation to a class 2B.” “Much of this decision to downgrade was based on the guideline committee’s goals to focus on the most recent data, to ensure that they were capturing contemporary stent technology, so they only evaluated studies published within the past 5 years,” continued Dr. Mehaffey. “Therefore, these guidelines relied heavily on the recently publicized ISCHEMIA trial, which looked at medical therapy in coronary artery disease, comparing an initial invasive approach versus a conservative approach to patients who had stable coronary artery disease.” The problem that arises when using ISCHEMIA to compare CABG to stenting is that the majority of patients in the ISCHEMIA trial were not representative of patients undergoing CABG in the US. Therefore, the study didn’t fully represent the comparative benefits for patients who had multiple blockages in their coronary arteries.   Dr. Mehaffey’s team sought to conduct a large contemporary analysis that more fully represented this population, comparing patients undergoing bypass surgery with those undergoing stenting. They, too, wanted to ensure that the study included only the most contemporary technology, so their longitudinal analysis captured outcomes over a 3-year period, 2018 to 2020. “We used one of the largest and most inclusive databases of patients hospitalized in the US, including all patients over the age of 65 on Medicare,” Dr. Mehaffey explained. “We performed a very robust statistical analysis including propensity score balancing to help ensure that the groups of patients who underwent stenting versus those who underwent bypass surgery were well matched and well balanced in order to compare their outcomes.” The population included more than 100,000 patients with multivessel coronary disease, with 51,000 patients undergoing CABG and 52,000 undergoing stenting. Analysis was performed by a multidisciplinary team that included cardiac surgeons, cardiologists, and researchers at West Virginia University. The analysis demonstrated a significantly lower hospital mortality for the patients who underwent CABG compared to those who underwent stenting. Additionally, the researchers found a marked reduction in both 30-day and 3-year readmissions for myocardial infarction. CABG patients were also significantly less likely to need any additional stenting or intervention on their coronary arteries during those 3 years, and—most significantly—those who underwent CABG had a nearly 60% reduction in death at 3 years compared to those who had stenting. “Regardless of your specialty, these data demonstrate the importance of assessing longitudinal outcomes to help ensure we’re making optimal treatment recommendations for our patients,” Dr. Mehaffey said. MORE ON THIS TOPIC AT STS 2023 To fully understand the implications of the latest science--which demonstrates that CABG is superior to stenting in multivessel coronary artery disease, don't miss: C. Walton Lillehei Lecture by Peter K. Smith: "Treatment Selection for Coronary Artery Disease: The Collision of a Belief System with Evidence" Monday, 9:00 a.m. PT "The ISCHEMIA Study Does Not Reflect Patients Undergoing Coronary Surgery: An STS Adult Cardiac Surgery Database Analysis" by Joseph F. Sabik III, MD Monday, 11:30 a.m. PT
Jan 17, 2023
4 min read
Dr. David Tom Cooke interviews Dr. Mark Orringer—a general thoracic surgery pioneer who developed the transhiatal esophagectomy, the most prevalent surgery for esophageal cancer.
1 hr. 3 min.

SAN DIEGO (January 18, 2023) – A scientific session devoted to identifying and closing gaps in health care will take place on Saturday at the Annual Meeting of The Society of Thoracic Surgeons (STS).

Jan 12, 2023
A scientific session devoted to identifying and closing gaps in health care will take place on Saturday at STS 2023. The session, beginning at 2:45 p.m. PT on January 21, will highlight evidence-proven programs that have not only identified disparities in health screening and treatment, but have successfully improved care for patients regardless of demographics, emphasized moderator Cherie P. Erkmen, MD, director of the lung screening and thoracic surgery residency programs for the Lewis Katz School of Medicine at Temple University in Philadelphia, Pennsylvania. Dr. Erkmen said, “One of the things we struggle against in the realm of diversity, equity, and inclusion is that people are tired of just hearing, ‘There’s disparity, there’s inequity, there’s a problem.’ But then—what do we do? That’s part of the focus of this session—health equity in practice and people who have embraced it, successfully increasing their volumes and improving patient outcomes.” Assembled by Dr. Erkmen and Sara Pereira, MD, from the University of Utah Health, presentations within the Symposium include a report on gender outcomes in coronary bypass grafting, racial disparities in the inpatient management of ischemic heart disease, increasing health equity in the heart and lung transplant arenas, mitigating disparities across the lifetimes of patients who have undergone congenital cardiac surgery, and strategies to improve adherence to lung cancer screening guidelines in underserved communities, based on researchers’ experience in rural South Carolina. “Dr. Tara Karamlou has examined the entire continuum of congenital cardiac surgery, from diagnosis through adulthood, and has opened her doors to understand a very challenging population,” Dr. Erkmen explained. “Dr. Yoshiya Toyoda is a transplant surgeon at a very underserved, ‘safety net’ hospital, yet he’s the number one lung transplanter in the country for several years straight, accepting people across the whole socioeconomic spectrum.” “We have a thoracic surgeon, Dr. Ian Bostock, who’s looking at diversity in lung cancer screening—understanding where the disparities lie and lowering the barriers to screening so that they can get through the door and to the next step, which is lung cancer treatment,” Dr. Erkmen continued. “The last speaker, Dr. Martha McGilvray, has been awarded the podium for her research on racial disparities in the management of ischemic heart disease.” Stepping in as co-moderator is Clauden Louis, MD, MS, from Brigham and Women’s Hospital in Boston, Massachusetts. “I’m excited to be considered to represent such a name—the story of Vivien Thomas is incredibly important,” Dr. Louis said. “I think STS is taking a stand toward valuing our patients and valuing representation, understanding that outcomes are improved when the people taking care of you also have an understanding or a similarity, and are able to represent the population.” The session is named for Vivien T. Thomas, a Black laboratory supervisor who worked with famed physician Alfred Blalock, MD, at Vanderbilt University in the 1940s. When Johns Hopkins recruited Dr. Blalock, he refused to move unless Thomas accompanied him as a “package deal.” Thomas worked as part of Dr. Blalock's surgical team, helping develop the procedure used in the landmark 1944 "blue baby" operation. Despite his integral role in Dr. Blalock’s pioneering work, Thomas was hired and paid as a janitor and was not allowed to use the main entrance to Johns Hopkins. “He’s someone who could’ve been me,” Dr. Louis said. In addition to the Symposium, the third annual Vivien T. Thomas Lecture will take place at STS 2023. This year, the lecture is presented by Francisco G. Cigarroa, MD, and will mark the commencement of the annual meeting on Saturday morning at 8:00 a.m. “I’m excited about getting interest and participation from our thoracic surgery residents and our junior faculty,” Dr. Erkmen said. “And it's also important for people to know that there is an enduring workforce from the STS headed up by Dr. David Tom Cooke. Under his steady leadership, we've been able to accomplish many, many additions to the cardiothoracic surgery community, including workforce publications, looking at workforce disparity and health disparity, and also coordinating with other committees to make sure that diversity is always in mind as we legislate ourselves and create a program like the STS Annual Meeting.” On Monday at STS 2023, Dr. Erkmen also will present “The Cost of Being a Woman in Academic Surgery,” a session that analyzes rank and salary throughout women surgeons’ careers and demonstrates the additional hurdles they face. “We know that there is a difference in care when you are focused on the end goal—better access for everyone,” Dr. Louis said. “I’m excited to represent Dr. Vivien Thomas as a moderator for this session. And I’m excited to meet my colleagues in San Diego.” STS is still accepting registrations for the annual meeting, offering both an in-person experience and a virtual option, Plenary Livestream-Plus, which allows registrants to stream select meeting content and plenary sessions—including the Thomas Lecture—from anywhere in the world. STS 2023 is the premier forum for presenting new science, techniques, and technology in cardiothoracic surgery. Learn more at STS.org/AnnualMeeting.
Jan 12, 2023
4 min read
“In the OR with” encounters, live exhibitor symposia, and extraordinary social events await attendees at the STS Annual Meeting in San Diego. “Attendance figures look as good as ever, but what is most energizing is the program,” said STS President John H. Calhoon, MD. “It is designed to give attendees some time … to not just talk about work/life balance, but to actually live it a bit.” STS 2023 registrants are highly encouraged to add ticketed “extras” to their registration, including the Presidents Reception and the Extraordinary Women in Cardiothoracic Surgery Awards Breakfast. The morning of Saturday, January 21 kicks off with the breakfast event, which will honor women surgeons who have achieved excellence in clinical practice and demonstrate integrity, leadership, creativity, and expertise in carrying out day-to-day duties and supporting the specialty. On Saturday evening, the Presidents Reception will be held at Coasterra, a bayfront restaurant and cocktail venue featuring a floating reception hall and a skyline lounge. Guests will make memories reuniting with—and meeting new—friends and colleagues. The event will celebrate not only the term of current STS President John H. Calhoon, MD, but also the legacies of Past Presidents Sean C. Grondin, MD, and Joseph A. Dearani, MD, who oversaw the Society’s governance with innovation and grace during the peak of the COVID-19 pandemic. “We have lost several admired colleagues in recent times, including Dr. Tweddell, Dr. Pagano, and Dr. Grondin,” said S. Adil Husain, MD, chair of the STS Workforce on Annual Meeting. “We will value our ability to celebrate their contributions to our subspecialty as well as to acknowledge the loss of other cherished members within our Society.” Space is limited for the reception and the breakfast, and attendees must add them to their carts during registration or to an existing registration. STS 2023 also heralds the return of live product demonstrations, with 150 exhibitors showcasing the latest tools and technologies for surgical practice. Industry symposia—both offsite and at the convention center this year—afford rare opportunities to practice new techniques, and product theaters let attendees experience devices and software hands-on. Between the conclusion of afternoon sessions and the Presidents Reception on Saturday, attendees can browse an exhibit hall opening reception and view presentations of scientific posters alongside their colleagues. Two half-hour coffee breaks on Sunday, January 22 give attendees more designated time to explore the exhibits and socialize at their leisure. “In the OR with …” experiences return with an added dimension of virtual reality, during which attendees can don headsets and virtually stand side-by-side with a master surgeon as they perform real-life operations including complex aortic arch reconstruction, uniport segmentectomy and left lower lobectomy, the Ross procedure, and minimally invasive mitral valve repair. Watch a teaser video.  There’s still time to register, add ticketed events, and start planning your San Diego experience at sts.org/annualmeeting.
Jan 9, 2023
3 min read
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
Event dates
Jan 27–29, 2024
Location
San Antonio, TX
Last month, Congress passed legislation that helps mitigate a nearly 9% cut to Medicare reimbursement for cardiothoracic surgery. Instead, cardiothoracic surgeons will experience a 2.08% decrease in reimbursement—which went into effect Jan. 1, 2023.  While the Society’s goal was to eliminate 100% of the pending cuts, its efforts as part of the Surgical Care Coalition (SCC) succeeded in substantially reducing the impact on surgeons in the interim. Throughout the course of 2022, the Society and its SCC partners engaged with legislators to stop the planned cuts.  “STS members who participated in advocacy efforts this year are to be commended for their contributions toward fixing a broken system,” said STS President John H. Calhoon, MD. “Our work will continue in 2023 or until Congress takes action on developing a long-term solution for Medicare payment.”  “These cuts are not sustainable going forward,” added Joseph Cleveland Jr., MD, chair of the STS Council on Health Policy and Relationships. “A long-term solution to Medicare reform is the most important thing in all of this in order to give cardiothoracic surgeons a degree of financial certainty to operate their practices. We need to be here so that we can take care of all patients with heart disease and cancer when they need us most.”  In addition to the Society’s individual efforts, STS’ legislative advocacy is greatly bolstered by its proactive role in the Surgical Care Coalition, a national coalition of 14 medical associations and societies that collectively represent 150,000 surgeons and anesthesiologists. Targeting Congressional leadership, the Surgical Care Coalition unifies the voice of the surgical profession on policy issues related to patient access and care quality. In addition to the Medicare cuts that just happened, Dr. Cleveland urges surgeons to think about some of the most profound long-term consequences that loom if drastic Medicare cuts continue; aging Baby Boomers may not be able to find cardiothoracic care if surgeons are forced to limit patients covered by Medicare. Further, he notes that tomorrow’s promising surgeons may choose not to enter the profession because of lengthy training, high educational debt, and unpredictable reimbursement—and patients will ultimately suffer. The US shortage of cardiothoracic surgeons is expected to reach severe levels by 2035, according to estimates derived from the STS Adult Cardiac Surgery Database and the American Cancer Society.    Although any surgeon who serves Medicare-covered patients will be impacted by these latest cuts, Dr. Cleveland adds that surgeons in rural or under-served areas and independent surgeons may be affected most. He urges STS members to take the following actions: 1. Make your views known to your federal and local lawmakers. Tell them that you want to take care of Medicare patients in their districts, but cuts might jeopardize this. Find contact information for members of Congress at congress.gov/contact-us. 2. Contribute to the STS Political Action Committee, which helps get surgeon advocates in front of legislators who can support surgeons. Donations can be made at pac.sts.org. 3. Participate in volunteer health policy work with STS that fits your preferences and time. Explore proactive opportunities at sts.org/advocacy or email advocacy@sts.org. “If we continue on the current path, we face an unsustainable crisis in providing care to our patients with heart and lung disease,” Dr. Cleveland said.
Jan 4, 2023
3 min read
Whether they know from the start that they’ll emulate their parents’ careers—or they fight tooth-and-nail to carve a different path—there seems to be something in the genes of cardiothoracic surgeons that pulls their children toward their calling.   Hal and Sophia Roberts For Harold “Hal” G. Roberts Jr., MD, and Sophia H. Roberts, MD, Barnes Jewish Hospital and Washington University in St. Louis, Missouri, is a cornerstone, an alma mater, and a workplace.  Last year, Dr. Hal Roberts joined the Barnes Jewish Heart and Vascular Center, transitioning from a South Florida private practice. He arrived a celebrated member of the surgical team, with more than 20 years of surgeries under his belt, a patent for a 3D mitral annuloplasty ring, the first publication to describe a modification of the Cox Maze IV right atrial lesion set, and a reputation for performing the first TAVR procedure in Broward County, Florida. And another singular distinction: Sophia’s dad.  “On ‘Take Your Child to Work Day,’ cardiothoracic surgeons can pretty much blow it out of the water by bringing their kid to the OR,” Sophia reflected. “Seeing the team dynamic and the real leadership that comes with being the attending surgeon had a lasting impact on me.”  Dr. Sophia Roberts adds that although her siblings didn’t go into medicine, they also considered the experience to be special—and fundamental to understanding their dad as a person.  “I tend to be a bit quieter than baseline,” she explained, “and that initially made me concerned for my ability to lead an operative team.” But observing her father, in addition to other attending surgeons and their diverse personalities, helped to assuage that concern. “I imagine that my leadership style will channel components of my dad and my other mentors,” Sophia said. “Particularly those who lead without being the loudest person in the room.” Dr. Sophia Roberts is a third-year resident at Washington University, and she’ll soon be assuming a senior resident role. Before Dr. Hal Roberts accepted the job, he made sure that he had Sophia’s blessing, because they’d be working in the same program.    Sophia has explored many facets of surgery during her training, but her father says that, just as he did, she found that she enjoyed caring for cardiac surgical patients the most.  “As far as Sophia deciding to go into cardiothoracic surgery, I was very flattered, but I made quite sure that she realized what she was getting into,” Dr. Hal Roberts said. “Cardiac surgery can be a physically and emotionally draining field, but it does give me great satisfaction in knowing that the quality and quantity of my patients’ lives are favorably impacted by the care I render.”  The new position at Barnes Jewish has afforded the elder Dr. Roberts the opportunity to teach—a realm he entered relatively late in his career. He calls it his greatest satisfaction, saying, “I have been amazed at how much fun this really is.”  For her academic development, Sophia is working through a fellowship in cardiovascular device innovation. “Delving into engineering is new terrain for me, and I am excited to carry our new devices from concept to pre-clinical testing,” she said, adding, “It’s pretty surreal to have a single dream for so long and then realize you’re living it.”  Dr. Hal Roberts hopes that his daughter will have exposure to classic as well as novel surgical approaches. “Though there will be more and more minimally invasive techniques on the horizon, I always think there will be a role for some of the basic procedures, like coronary artery revascularization, that we have been effectively doing for years.”  David and John Cleveland “We’re both extremely pragmatic, to both benefit and fault at times,” says John Cleveland, MD, of himself and his father, David C. Cleveland, MD, MBA. The elder Dr. Cleveland is an associate professor of surgery at the Heersink School of Medicine, part of the University of Alabama at Birmingham. He’s a giant in congenital heart surgery, having served as chief of pediatric cardiac surgery for the Children’s Hospital in Buffalo, New York, the Children’s Hospital at Medical City Dallas in Texas, and St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. At St. Joseph’s, he founded the Eller Congenital Heart Center and served as its executive director.  As a kid, John Cleveland was acutely aware of the demands of his father’s profession, which often pulled the elder Dr. Cleveland away from time with his wife and three children. He missed some of his kids’ big milestones, from music recitals to winning touchdowns, because he was working to save the lives of “other people’s kids.”  Even so, John was drawn to a surgical career himself—but he was determined to find a course that wouldn’t cause him to miss out on moments with his own budding family. He leaned toward reconstructive plastic surgery.   John’s internship years brought an encounter that for most would be incandescent: He helped treat a man who had been mauled by a grizzly bear. But while his fellow trainees were thrilled at the opportunity to perform a potentially once-in-a-career reconstruction, John realized that he didn’t feel the same rush.   Plastic surgery wasn’t for him, he now understood—and he was just weeks away from starting a plastic surgery residency. Luckily, he was able to slide into a surgical rotation in a different specialty.  “In the operating room, a veteran doctor threw question after question at the rookie,” recounted a feature by the American Heart Association. “Even as the queries became more complex, John—who’d never studied this area, much less trained in it—aced the quiz. The look on the veteran doctor’s face sent John a clear message.”  The area was cardiac surgery. Specifically, pediatric cardiac surgery. And John was a natural.  Since those days, Drs. John and David have developed a deeper understanding of one another—and of how they both lamented the moments they missed.  “I have been surprised by the manner in which my career has allowed me to see my father from a different perspective,” John reflected. “Now that I am a dad myself, working in the same field, I have come to better terms with the demands that this job places on you and how much it can compete with family life. It has certainly increased my empathy and understanding of how my dad had to do things growing up.”  It has also helped John approach his career decisions with a savviness for work/life balance that wasn’t as feasible for his dad.  Dr. David Cleveland was often a lone ship in his profession, having at most one surgical partner to cover for him in an emergency. Dr. John Cleveland landed a fellowship at Children’s Hospital Los Angeles (CHLA) in California, which has a large surgical staff that he described as virtually interchangeable because of their top-notch skillsets.  “I am entering my fourth year as an attending and have taken over as the program director for our congenital heart surgery training program,” Dr. John Cleveland said. “I’m looking forward to continue matching high-quality applicants that our group of surgeons can mold into excellent technicians as well as thoughtful bedside physicians who care for children with congenital heart disease.”  As his career and family have blossomed, John has happily stayed with CHLA, and it allows him the freedom to be present for moments like birthdays and softball games.  The senior Dr. Cleveland recently celebrated a milestone of his own. He has retired from clinical practice, and he’ll now have the time to not only make memories with his kids and grandkids but also to pick up a research project for which he completed pilot data before the pandemic. He and John are working collaboratively. “We are transplanting genetically modified pig hearts into infant baboons with the intention to translate this to clinical care of neonates and infants as a bridge to cardiac allotransplant,” Dr. John Cleveland said. “The current technology used to bridge this fragile patient population is fraught with complications and risk. We believe xenotransplant will prove to be safer and a more appropriately tailored option for these small children.”  The research is funded, Dr. Cleveland said, and it’s slated to kick off this month. If you know of a unique member experience that should be featured in STS News, contact stsnews@sts.org.
Jan 4, 2023
7 min read